# Unicycive Therapeutics, Inc.: Form 8-K/A, filed Apr 14, 2025

- Company: [Unicycive Therapeutics, Inc.](/companies/uncy.md) (CIK 1766140)
- Form: 8-K/A
- Filed: 2025-04-14
- Accepted by EDGAR: Apr 14, 2025, 16:30 ET
- Period: 2024-03-13
- Accession: 0001213900-25-031593
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/ea0237290-8ka1_unicyc.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/ea0237290-8ka1_unicyc.htm

Filed Apr 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-031593. Last ingested by Listed: Oct 29, 2026, 16:30 ET. No prices; not investment advice.
